Non-alcoholic fatty liver disease is associated with progression of arterial stiffness

被引:36
|
作者
Li, N. [1 ]
Zhang, G. -W. [2 ]
Zhang, J. -R. [3 ]
Jin, D. [3 ]
Li, Y. [3 ,4 ]
Liu, T. [5 ]
Wang, R. -T. [3 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin 150086, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Harbin 150086, Heilongjiang, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin 150086, Heilongjiang, Peoples R China
[4] Harbin Med Univ, Affiliated Hosp 2, Int Phys Examinat & Healthy Ctr, Harbin 150086, Heilongjiang, Peoples R China
[5] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA
关键词
Non-alcoholic fatty liver disease; Brachial-ankle pulse wave velocity; Arterial stiffness; PULSE-WAVE VELOCITY; EPICARDIAL ADIPOSE-TISSUE; C-REACTIVE PROTEIN; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; RISK-FACTOR; INDIVIDUALS; MORTALITY; CHINESE; COHORT;
D O I
10.1016/j.numecd.2014.10.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: NAFLD is an independent risk factor for increased cardiovascular disease. Arterial stiffness is an index of subclinical atherosclerosis. The aims of this study were to examine prospectively the relationship between Non-alcoholic fatty liver disease (NAFLD) and the progression of arterial stiffness. Methods and results: A prospective study of 728 men and 497 women free of hypertension, and diabetes at the baseline were conducted. The subjects were followed for 5 years. The progression rate of arterial stiffness was measured by calculating the increase in brachial-ankle pulse wave velocity (baPWV) the changes of the baPWV (adjusted for age) during the study period was significantly greater in the patients with NAFLD (172.4 +/- 42.1 cm/s for men, 95.8 +/- 36.7 cm/s for women) than in the subjects without NAFLD (70.3 +/- 56.5 cm/s for men, 55.4 +/- 42.2 cm/s for women). For the subjects with metabolic syndrome, after adjusting for multiple risk factors, NAFLD was a significant predictor of baPWV progression (for male, beta = 0.843; P < 0.001; for female, beta = 0.575; P < 0.001, respectively). In addition, results were unmodified in subjects without metabolic syndrome. Conclusions: NAFLD was found to be an independent predictor of faster progression of baPWV even after adjusting other cardiovascular risk factors. These prospective data support a pathogenic role for NAFLD in the development of arterial stiffness. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:218 / 223
页数:6
相关论文
共 50 条
  • [1] Increased whole blood viscosity associated with arterial stiffness in patients with non-alcoholic fatty liver disease
    Yu, Kai-jiang
    Zhang, Mei-jie
    Li, Ying
    Wang, Rui-tao
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (03) : 540 - 544
  • [2] Non-Alcoholic Fatty Liver Disease and Aterial Stiffness
    Mariano, Duarte
    Gonzalez, Ballerga Esteban
    Jorge, Daruich
    Vazquez, Blanco Manuel
    Juan, Sorda A.
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2013, 15
  • [3] Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension
    Catena, C.
    Bernardi, S.
    Sabato, N.
    Grillo, A.
    Ermani, M.
    Sechi, L. A.
    Fabris, B.
    Carretta, R.
    Fallo, F.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2013, 23 (04) : 389 - 393
  • [4] Angiogenesis in the progression of non-alcoholic fatty liver disease
    Lefere, S.
    Devisscher, L.
    Geerts, A.
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2020, 83 (02) : 301 - 307
  • [5] ARTERIAL STIFFNESS IS INDEPENDENTLY ASSOCIATED WITH LIVER STIFFNESS IN BIOPSY-PROVEN NON-ALCOHOLIC FATTY LIVER DISEASE: A TRANSIENT ELASTOGRAPHY STUDY
    Bilgin, Beyza Oren
    Sunbul, Murat
    Kani, Haluk Tarik
    Demirtas, Coskun Ozer
    Keklikkiran, Caglayan
    Yilmaz, Yusuf
    [J]. HEPATOLOGY, 2019, 70 : 1063A - 1064A
  • [6] Progression of liver stiffness and the development of cirrhosis in histologically characterized patients with non-alcoholic fatty liver disease
    Chalasani, Naga
    Van Natta, Mark
    Gawrieh, Samer
    Vuppalanchi, Raj
    Sanyal, Arun
    Loomba, Rohit
    Tonascia, James
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S72 - S73
  • [7] LIVER STIFFNESS, BUT NOT NON-ALCOHOLIC FATTY LIVER DISEASE, IS ASSOCIATED WITH ATRIAL FIBRILLATION: THE ROTTERDAM STUDY
    Van Kleef, Laurens A.
    Lu, Zuolin
    Kavousi, Maryam
    De Knegt, Robert J.
    [J]. HEPATOLOGY, 2021, 74 : 1022A - 1023A
  • [8] Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease
    Yilmaz, Yusuf
    Eren, Fatih
    [J]. ATHEROSCLEROSIS, 2019, 290 : 222 - 223
  • [9] The Role of Epigenetics in the Progression of Non-Alcoholic Fatty Liver Disease
    Edith Aguilar-Olivos, Nancy
    Oria-Hernandez, Jesus
    Ponciano-Rodriguez, Guadalupe
    Carlos Chavez-Tapia, Norberto
    Uribe, Misael
    Mendez-Sanchez, Nahum
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2015, 15 (14) : 1187 - 1194
  • [10] Genetic modifiers of non-alcoholic fatty liver disease progression
    Anstee, Quentin M.
    Daly, Ann K.
    Day, Christopher P.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (11): : 1557 - 1566